↓ Skip to main content

A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID)

Overview of attention for article published in BMC Infectious Diseases, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
twitter
1 tweeter

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID)
Published in
BMC Infectious Diseases, January 2020
DOI 10.1186/s12879-019-4751-3
Pubmed ID
Authors

Mary T. Bessesen, Gheorghe Doros, Adam M. Henrie, Kelly M. Harrington, John A. Hermos, Robert A. Bonomo, Ryan E. Ferguson, Grant D. Huang, Sheldon T. Brown

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 114 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 20%
Student > Master 15 13%
Unspecified 8 7%
Researcher 6 5%
Other 5 4%
Other 19 17%
Unknown 38 33%
Readers by discipline Count As %
Nursing and Health Professions 22 19%
Medicine and Dentistry 15 13%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Unspecified 8 7%
Psychology 4 4%
Other 13 11%
Unknown 44 39%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2022.
All research outputs
#3,174,304
of 22,668,244 outputs
Outputs from BMC Infectious Diseases
#1,047
of 7,640 outputs
Outputs of similar age
#79,040
of 453,330 outputs
Outputs of similar age from BMC Infectious Diseases
#18
of 177 outputs
Altmetric has tracked 22,668,244 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,640 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,330 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.